Papers/PMID:22277556
Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up.
The American journal of clinical nutrition2012The record
2 findings · 1 compound · 2 endpoints
What it reported
How to read these marksWhat moved
2 findings
riboflavin — decreases diastolic blood pressure (setting unspecified)
Evidence strength: very limited.Finding“Riboflavin supplementation (administered in 2004 and 2008) produced an overall decrease in systolic (-9.2 ± 12.8 mm Hg; P = 0.001) and diastolic (-6.0 ± 9.9 mm Hg; P = 0.003) BP.”
Quoted verbatim from Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up.. - Study
- crossover
- Duration
- 4 months
- Dose
- 1.6 mg/d for 16 wk
- Population
- Patients with the MTHFR 677TT genotype (n = 31 of 83 follow-up participants), crossover in which the 2004 treatment groups were reversed; effect pooled over the 2004 and 2008 interventions
Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up.2012PMID:2227755610.3945/ajcn.111.026245Permalink
riboflavin — decreases systolic blood pressure (setting unspecified)
Evidence strength: very limited.Findingreplicated ×1“Riboflavin supplementation (administered in 2004 and 2008) produced an overall decrease in systolic (-9.2 ± 12.8 mm Hg; P = 0.001) and diastolic (-6.0 ± 9.9 mm Hg; P = 0.003) BP.”
Quoted verbatim from Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up.. - Study
- crossover
- Duration
- 4 months
- Dose
- 1.6 mg/d for 16 wk
- Population
- Patients with the MTHFR 677TT genotype (n = 31 of 83 follow-up participants), crossover in which the 2004 treatment groups were reversed; effect pooled over the 2004 and 2008 interventions
Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up.2012PMID:2227755610.3945/ajcn.111.026245Permalink